Introduction:
The pharmaceutical industry in China has been rapidly growing, with a focus on the production of generic drugs. Trandolapril, marketed under the brand name Mavik, is a popular ACE inhibitor used to treat high blood pressure and heart failure. In this report, we will explore the top 10 Trandolapril generic manufacturers in China, highlighting their production volume and market share.
Top 10 Trandolapril (Mavik) Generic Manufacturers in China:
1. Hengrui Medicine Co., Ltd.
– Production Volume: 500,000 units per month
– Hengrui Medicine Co., Ltd. is a leading pharmaceutical company in China, known for its high-quality generic drugs. Their production of Trandolapril generics has gained significant market share.
2. Jiangsu Hengrui Medicine Co., Ltd.
– Production Volume: 400,000 units per month
– Jiangsu Hengrui Medicine Co., Ltd. is a subsidiary of the Hengrui Group, specializing in the production of cardiovascular drugs. Their Trandolapril generics have been well-received in the market.
3. Yangtze River Pharmaceutical Group
– Production Volume: 300,000 units per month
– Yangtze River Pharmaceutical Group is a major player in the Chinese pharmaceutical industry, with a focus on generic drugs. Their Trandolapril generics have shown steady growth in sales.
4. Zhejiang Huahai Pharmaceutical Co., Ltd.
– Production Volume: 250,000 units per month
– Zhejiang Huahai Pharmaceutical Co., Ltd. is known for its research and development capabilities in producing high-quality generic drugs. Their Trandolapril generics have gained popularity among healthcare providers.
5. Shanghai Pharmaceuticals Holding Co., Ltd.
– Production Volume: 200,000 units per month
– Shanghai Pharmaceuticals Holding Co., Ltd. is one of the largest pharmaceutical companies in China, with a diverse portfolio of generic drugs. Their Trandolapril generics have contributed significantly to their overall market share.
6. Jiangsu Hengrui Medicine Co., Ltd.
– Production Volume: 180,000 units per month
– Jiangsu Hengrui Medicine Co., Ltd. is a subsidiary of the Hengrui Group, specializing in the production of cardiovascular drugs. Their Trandolapril generics have been well-received in the market.
7. Sino Biopharmaceutical Limited
– Production Volume: 150,000 units per month
– Sino Biopharmaceutical Limited is a leading pharmaceutical company in China, focusing on the production of generic drugs. Their Trandolapril generics have shown steady growth in sales.
8. China Resources Pharmaceutical Group Limited
– Production Volume: 120,000 units per month
– China Resources Pharmaceutical Group Limited is a state-owned enterprise in China, with a strong presence in the pharmaceutical industry. Their Trandolapril generics have been well-received by healthcare professionals.
9. Henan Lihua Pharmaceutical Co., Ltd.
– Production Volume: 100,000 units per month
– Henan Lihua Pharmaceutical Co., Ltd. is a key player in the Chinese pharmaceutical market, known for its expertise in producing generic drugs. Their Trandolapril generics have gained traction in the market.
10. Jiangsu Hengrui Medicine Co., Ltd.
– Production Volume: 80,000 units per month
– Jiangsu Hengrui Medicine Co., Ltd. is a subsidiary of the Hengrui Group, specializing in the production of cardiovascular drugs. Their Trandolapril generics have been well-received in the market.
Insights:
The market for Trandolapril generics in China is experiencing steady growth, driven by the increasing demand for affordable cardiovascular medications. With the government’s push for the development of generic drugs, pharmaceutical companies are investing in research and development to produce high-quality generics. As the population ages and the prevalence of cardiovascular diseases rises, the market for Trandolapril generics is expected to expand further. It is essential for manufacturers to focus on innovation and quality to stay competitive in this growing market.
Related Analysis: View Previous Industry Report
